课题基金 / 基金详情

Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation

Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation
妊娠期间抑制白介素 1 受体可预防胎盘/绒毛膜羊膜炎症引起的新生儿死亡和发病
批准号:
347896
负责人:
Nadeau-Valle Mathieu
金额:
$7.65万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-10-01 至 2018-10-01

项目摘要

项目成果

Nadeau-Valle Mathieu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Inflammation inside the uterus is responsible for most of pregnancy complications, including preterm birth, placental dysfunctions and premature rupture of membranes. Those complications are the leading cause of neonatal mortality and morbidity, and are a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation
  • 批准号:
    339562
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $10.93万
  • 财政年份:
    2015
  • 负责人:
    Nadeau-Valle Mathieu
  • 依托单位:
Characterisation of a Small Non-Competitive Peptide Inhibitor of IL-1RI in Preterm Labor
  • 批准号:
    331286
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $1.27万
  • 财政年份:
    2014
  • 负责人:
    Nadeau-Valle Mathieu
  • 依托单位:
海外基金